Thalidomide: Following Tragedy, a Repurposed Molecule With Continuing Opportunities for Clinical Benefit
- PMID: 39947980
- DOI: 10.1016/j.clinthera.2025.01.011
Thalidomide: Following Tragedy, a Repurposed Molecule With Continuing Opportunities for Clinical Benefit
Publication types
LinkOut - more resources
Full Text Sources
